Global Liver-specific Assays Service Market Growth (Status and Outlook) 2025-2031

The global Liver-specific Assays Service market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Liver-specific assays service refers to a specialized laboratory service that focuses on testing and analyzing various parameters related to liver function and health. These assays are specifically designed to assess the activity and integrity of the liver, as well as to detect any abnormalities or diseases affecting the liver.

Liver-specific assays may include tests such as liver enzyme tests (e.g., alanine aminotransferase, aspartate aminotransferase), liver function tests (e.g., bilirubin, albumin), coagulation tests (e.g., prothrombin time, international normalized ratio), viral hepatitis tests (e.g., hepatitis B surface antigen, hepatitis C antibody), and tests for liver diseases (e.g., alpha-fetoprotein, autoimmune liver disease markers).

These assays are typically performed on blood samples collected from individuals suspected of having liver disorders or as part of routine health check-ups. The results of these tests can provide valuable information about liver function, diagnose liver diseases, monitor the progression of liver diseases, and assess the effectiveness of treatments.

Liver-specific assays service is usually offered by specialized clinical laboratories or diagnostic centers that have the necessary expertise and equipment to perform these tests accurately and efficiently. The service may be requested by healthcare providers, such as doctors or hepatologists, to aid in the diagnosis and management of liver-related conditions.

United States market for Liver-specific Assays Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Liver-specific Assays Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Liver-specific Assays Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Liver-specific Assays Service players cover Solvo Biotechnology, Cyprotex, MB Biosciences, Visikol, InSphero, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Liver-specific Assays Service Industry Forecast” looks at past sales and reviews total world Liver-specific Assays Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Liver-specific Assays Service sales for 2025 through 2031. With Liver-specific Assays Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liver-specific Assays Service industry.

This Insight Report provides a comprehensive analysis of the global Liver-specific Assays Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Liver-specific Assays Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Liver-specific Assays Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liver-specific Assays Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liver-specific Assays Service.

This report presents a comprehensive overview, market shares, and growth opportunities of Liver-specific Assays Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
Hepatocyte Uptake Assay
Hepatocyte clearance assay
Hepatocyte Biliary Excretion Assay
Hepatocyte Functional polarity assay
Hepatic phospholipidosis assay
Hepatic cholestasis assay
Other

Segmentation by Application:
Laboratory
Hospital

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Solvo Biotechnology
Cyprotex
MB Biosciences
Visikol
InSphero

Please note: The report will take approximately 2 business days to prepare and deliver.